From GlobeNewswire: 2025-05-07 08:45:00

Inspira Technologies OXY B.H.N. Ltd. received approval from Israel’s largest healthcare provider to validate the INSPIRA ART100 system for use in organ transplant procedures. The FDA-approved system will be tested by leading physicians at a renowned medical center in Israel. The system aims to maintain organ viability through advanced blood oxygenation, providing out-of-body oxygenation during the transplant procedure and in the recovery room. This validation process will provide valuable insights for the development of the INSPIRA ART500 system, which aims to revolutionize respiratory care by providing direct blood oxygenation without mechanical ventilation.



Read more at GlobeNewswire: INSPIRA ART100 System Approved by Israel’s Largest